European Launch of Calprotectin Immunoturbidimetric Assay Announced
ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial.
Read MorePosted by Chris Wolski | May 9, 2025 | Immunoassay Reagents & test Kits |
ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial.
Read MorePosted by Chris Wolski | May 8, 2025 | Diabetes & Metabolic Diseases |
Nordic Bioscience’s PRO-C3 test, now launched globally by Roche Diagnostics on cobas analyzers, offers a way to assess liver fibrosis.
Read MorePosted by Chris Wolski | May 7, 2025 | Cancer |
New predictive algorithms using routine health data and blood tests significantly improve early detection of 15 cancers.
Read MorePosted by Chris Wolski | May 6, 2025 | Breast |
A new peer-reviewed study confirms that Ibex Breast significantly enhances accuracy, speed, and efficiency of breast pathology evaluations.
Read MorePosted by Chris Wolski | May 5, 2025 | Lung Cancer |
Roche’s VENTANA TROP2 RxDx Device, a computational companion diagnostic, has received FDA Breakthrough Device Designation.
Read More